The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Review of Pharmacologic Weight Loss Medications in a Patient-Centered Medical Home
Open accessAbstract
Background: Per the Centers for Disease Control, 78 million adults were classified as obese in the United States in 2009 to 2010. Lifestyle modifications and pharmacologic treatment are appropriate options to combat obesity. Objectives: The primary objective of the study was to assess change in body weight after 12 weeks in patients seen at a family medicine patient-centered medical home (PCMH) who were prescribed Food and Drug Administration–approved weight loss medications. Methods: A retrospective medical record review was used to evaluate weight loss in adult patients with office visits at the PCMH. Adult patients were eligible for inclusion in the study if prescribed a Food and Drug Administration approved weight loss medication between July 1, 2013, and March 31, 2014, and had at least one weight documented during a follow-up visit 12 weeks after the initial prescription. Results: Of the 27 patients identified for study inclusion, 22 (81.5%) were prescribed phentermine. The remaining 5 (18.5%) patients were prescribed phentermine/topiramate ER. After 12 weeks of pharmacologic therapy, the median change in body weight was −3.7 kg (range = −16.8 to 5.5 kg) regardless of medication taken. This correlates to a −1.4 kg/m 2 (range = −15.7 to 4.2 kg/m 2 ) median change in body mass index. Twelve patients (44.4%) lost at least 5% of their body weight during the study period. Conclusions: In our study population, we observed a median weight loss of 3.7 kg over 12 weeks while utilizing weight loss medications. Unfortunately, other lifestyle-modification services offered through the PCMH were not consistently utilized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347 · cited 5×
“Many risks are associated with obesity such as morbidity and mortality from hypertension, dyslipidemia, type 2 diabetes mellitus, coronary heart disease, stroke, gallbladder disease, osteoarthritis, sleep apnea, respiratory problems, and cancer.(1,2) With the overwhelming number of obese adults determined in 2009, it…”
BackgroundInfluentialMeta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Garvey, W. T., Ryan, D. H., Look, M., Gadde, K. M., Allison, D. B., Peterson, C. A., Schwiers, M., Day, W. W., & Bowden, C. H. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.024927 · Cited by 716
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Fidler, M. C., Sanchez, M., Raether, B., Weissman, N. J., Smith, S. R., Shanahan, W. R., & Anderson, C. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1256 · Cited by 561
Obesity management: update on orlistat.
Drew, B. S., Dixon, A. F. R., & Dixon, J. B. (2007) · PubMed Central · Cited by 203
Research works printed but not linked: 3
- Sweeting AN, 2014, Diabetes Metab Syndr Obes, 7, 35
- Drew BS, 2007, Vasc Health Risk Manag, 3, 817
- Thygeson NM, 2013, Mixed Methods: Fuzzy Set Qualitative Comparative Analysis and Configurational Comparative Methods: Powerful Methods to Study and Refine Patient-Centered Medical Home Models
Cited by
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31982 · Cited by 238
Ahmad, N. N., Robinson, S., Kennedy‐Martin, T., Poon, J. L., & Kan, H. (2021) · Obesity Reviews · doi:10.1111/obr.13326 · Cited by 69
Effectiveness and safety of drugs for obesity
Henderson Lewis, K., Sloan, C. E., Bessesen, D. H., & Arterburn, D. (2024) · BMJ · doi:10.1136/bmj-2022-072686 · Cited by 66
Impact of Health Literacy on Weight Loss in Obese Individuals
Demirci, Z. Y. A. H., & Demirci, H. (2021) · European Health Literacy Journal · doi:10.29228/ehlj.50815 · Cited by 2
Medicine as a Job and Not as a Career—Recruiting and Retaining an Evolving Physician Workforce
Poole, K., & Seidel, Z. (2022) · Physician leadership journal · doi:10.55834/plj.3216612343 · Cited by 1
Metadata
- Authors
- Costello, T., Dorrell, M., Kellams, T., & Kraska, K.
- Affiliations
- Butler University (US)
- Community Health Network (US)
- CVS Health (United States) (US)
- Jewel-Osco Pharmacy, Chicago, IL, USA
- Corresponding author
- Costello, Tracy
- Venue
- Journal of Pharmacy Technology
- Publisher
- SAGE Publications
- Published
- 2015-09-11
- Volume
- 32
- Issue
- 1
- Pages
- 37-41
- ISSN
- 1549-4810 (ISSN-L)
- 8755-1225
- PMC
- PMC5998407
- OpenAlex
- W2226471372
- Semantic Scholar
- 32ce2699c7576e4b3b4f21c44f026059a3aff106
- Cited by
- 5
- References
- 7
- Citations by year
- 2024: 1 · 2022: 2 · 2021: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Pharmacy Technology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, obesity, patient-centered medical home, phentermine, phentermine/topiramate, weight change, body mass index, lifestyle modification, general practice, medication adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review of Pharmacologic Weight Loss Medications in a Patient-Centered Medical Home. https://app.cochat.ai/papers/10.1177/8755122515604858
- The paper
- Costello, T., Dorrell, M., Kellams, T., & Kraska, K. (2016). Review of Pharmacologic Weight Loss Medications in a Patient-Centered Medical Home. Journal of Pharmacy Technology. https://doi.org/10.1177/8755122515604858
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.